Literature DB >> 12531559

Differentiation of murine preosteoblastic KS483 cells depends on autocrine bone morphogenetic protein signaling during all phases of osteoblast formation.

G van der Horst1, R L van Bezooijen, M M L Deckers, J Hoogendam, A Visser, C W G M Löwik, M Karperien.   

Abstract

In this study, we examine the role of bone morphogenetic protein (BMP) signaling during differentiation of the murine preosteoblastic KS483 cell line, which formed alkaline phosphatase (ALP)-positive and mineralized nodules during a 3 week culture period. Semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) demonstrated the presence of various BMPs (BMP-2, -3, -4, -6, -7, and -8A and -8B), BMP type I and II receptors (ALK2, ALK3, ALK4, BMPR-II, and ActR-IIA and -IIB), BMP antagonists (DAN, gremlin, chordin, cerberus, noggin, and tsg), and Smads 1-8. mRNA expression of these genes did not change during differentiation, except for BMP-3, BMP-8a, and noggin. BMP-3 increased gradually, particularly in the matrix formation phase; BMP-8a was induced from the onset of matrix maturation and mineralization, in parallel to the expression of osteocalcin; and noggin tended to decline during the mineralization phase. Treatment of KS483 cells with the BMP antagonists noggin or soluble truncated BMPR-IA, either continuously or during distinct periods of osteoblast differentiation; that is, matrix formation or matrix maturation and mineralization phase, decreased ALP-positive and mineralized nodule area independent of the phase of osteoblast differentiation. Notably, the antagonists inhibited mineralization of already existing nodules. Similarly, BMP-4 stimulated differentiation not only at the beginning of the culture period, but also at late stages of differentiation. These data indicate that autocrine BMP signaling is involved in KS483 osteoblastic differentiation not only during the early phase of differentiation, but also during matrix maturation and mineralization. The different expression patterns of components of BMP signaling in the KS483 cells suggest distinct functions of individual BMPs during osteoblast differentiation. In summary, our data suggest that BMP activity is required not only for initiation of osteoblast differentiation and further development of early osteoblasts, but is also involved in late-stage osteoblast differentiation and matrix mineralization. Copyright 2002 by Elsevier Science Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12531559     DOI: 10.1016/s8756-3282(02)00903-1

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  16 in total

1.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.

Authors:  David G Winkler; May Kung Sutherland; James C Geoghegan; Changpu Yu; Trenton Hayes; John E Skonier; Diana Shpektor; Mechtild Jonas; Brian R Kovacevich; Karen Staehling-Hampton; Mark Appleby; Mary E Brunkow; John A Latham
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

2.  Osteoblast-like cell response to calcium phosphate coating chemistry and morphology on etched silicon surfaces.

Authors:  George A Burke; Chris J Rea; Fergal G Horgan; Marie Turkington; Adrian R Boyd; Brian J Meenan
Journal:  J Mater Sci Mater Med       Date:  2012-03       Impact factor: 3.896

3.  Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.

Authors:  Ruth Schwaninger; Cyrill A Rentsch; Antoinette Wetterwald; Geertje van der Horst; Rutger L van Bezooijen; Gabri van der Pluijm; Clemens W G M Löwik; Karin Ackermann; Walter Pyerin; Freddie C Hamdy; George N Thalmann; Marco G Cecchini
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.

Authors:  Richard W J Groen; Martin F M de Rooij; Kinga A Kocemba; Rogier M Reijmers; Anneke de Haan-Kramer; Marije B Overdijk; Linda Aalders; Henk Rozemuller; Anton C M Martens; P Leif Bergsagel; Marie José Kersten; Steven T Pals; Marcel Spaargaren
Journal:  Haematologica       Date:  2011-08-09       Impact factor: 9.941

5.  Endogenous BMPR-IB signaling is required for early osteoblast differentiation of human bone cells.

Authors:  Weerachai Singhatanadgit; Irwin Olsen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-12-07       Impact factor: 2.416

6.  Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiation.

Authors:  Hongbin Liu; Rongrong Zhang; Di Chen; Babatunde O Oyajobi; Ming Zhao
Journal:  J Cell Physiol       Date:  2012-03       Impact factor: 6.384

7.  Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways.

Authors:  Carola Krause; Olexandr Korchynskyi; Karien de Rooij; Stella E Weidauer; David J J de Gorter; Rutger L van Bezooijen; Sarah Hatsell; Aris N Economides; Thomas D Mueller; Clemens W G M Löwik; Peter ten Dijke
Journal:  J Biol Chem       Date:  2010-10-15       Impact factor: 5.157

8.  BMP-6 exerts its osteoinductive effect through activation of IGF-I and EGF pathways.

Authors:  W A Grasser; I Orlic; F Borovecki; K A Riccardi; P Simic; S Vukicevic; V M Paralkar
Journal:  Int Orthop       Date:  2007-07-19       Impact factor: 3.075

9.  Noggin recruits mesoderm progenitors from the dorsal aorta to a skeletal myogenic fate.

Authors:  Gonzalo Ugarte; Ornella Cappellari; Laura Perani; Anna Pistocchi; Giulio Cossu
Journal:  Dev Biol       Date:  2012-02-18       Impact factor: 3.582

10.  A specific role for phosphoinositide 3-kinase and AKT in osteoblasts?

Authors:  Imelda M McGonnell; Agamemnon E Grigoriadis; Eric W-F Lam; Joanna S Price; Andrew Sunters
Journal:  Front Endocrinol (Lausanne)       Date:  2012-07-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.